{"schema_version":"secwatch.filing_event.v1","accession":"0001837607-24-000079","form_type":"8-K","ticker":"AEON","cik":"0001837607","company_name":"AEON Biopharma, Inc.","filed_at":"2024-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.810951+00:00","generated_at":"2026-05-31T12:36:44.862842+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"AEON Biopharma posts new corporate presentation; no financial updates disclosed","bullets":["New corporate presentation posted on August 6, 2024, highlighting PrabotulinumtoxinA as a biosimilar candidate.","The filing does not disclose any financial results, guidance, or clinical data updates.","No changes to business strategy or pipeline were announced in the 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001837607-24-000079","json":"https://secwatch.observer/filing/0001837607-24-000079.json","markdown":"https://secwatch.observer/filing/0001837607-24-000079.md","text":"https://secwatch.observer/filing/0001837607-24-000079.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1837607/000183760724000079/0001837607-24-000079-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1837607/000183760724000079/aeon-20240806x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T12:36:44.862842+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}